Kazia Therapeutics

Kazia Therapeutics is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Kazia Therapeutics collaborates with leading scientists, clinicians, and investors around the world.

Industries

Biotechnology

Headquarters

Sydney, Australia

Stage

Post IPO Equity

Employees

11-50

Links

Org chart

James Garner

CEO

Collapse

Gabrielle H.

Vice President, Finance and Administration

John Friend

Chief Medical Officer

Robert Kennedy

VP Corporate Relations

Teams

View all

Board of Directors

8 members

CEO and Executive Team

1 members

Leadership Team

1 members

Discover similar companies

Alterity Therapeutics

Parkville, Australia · Post IPO Equity

Benitec Biopharma

Balmain, Australia · Post IPO Equity

DroneShield

Sydney, Australia · Post IPO Equity

Vow

Sydney, Australia · Series A

Organicell

Miami Beach, United States · Post IPO Equity

Kadimastem

Ness Ziona, Israel · IPO

Pacific Edge

Dunedin, New Zealand · Post IPO Equity

89bio

San Francisco, United States · Post IPO Equity

Day One Biopharmaceuticals

South San Francisco, United States · Post IPO Equity

Gemini Therapeutics

Cambridge, United States · Post IPO Equity

Mereo BioPharma

New York, United States · Post IPO Equity

Nuheara

Northbridge, Australia · IPO

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.